J Acquir Immune Defic Syndr by Ciampa, Philip J. et al.
Addressing poor retention of infants exposed to HIV: a quality
improvement study in rural Mozambique
Philip J. Ciampa, MD, MPH1,4, Jose Tique, MD1,3, Nilton Jumá, MD3, Mohsin Sidat, MD,
PhD2, Troy D. Moon, MD, MPH1,3, Russell L. Rothman, MD,MPP4, and Sten H. Vermund,
MD, PhD1
1Vanderbilt Institute for Global Health, Vanderbilt University School of Medicine, 2525 West End
Avenue, Suite 725, Nashville, Tennessee 37203, USA
2Universidade Eduardo Mondlane, Av. Salvador Allende 702, Maputo, Mozambique
3Friends in Global Health, LLC, Avenida dos Trabalhadores N°424, Quelimane, Mozambique
4Division of General Internal Medicine and Public Health, Vanderbilt University, D-3100 Medical
Center North, Nashville, TN, 37232, USA
Abstract
Objective—Early infant diagnosis (EID) is the first step in HIV care, yet 75% of HIV-exposed
infants born at two hospitals in Mozambique failed to access EID.
Design—Before/after study.
Setting—Two district hospitals in rural Mozambique.
Participants—HIV-infected mother/HIV-exposed infant pairs (N=791).
Intervention—We planned two phases of improvement using quality improvement methods. In
Phase 1, we enhanced referral by offering direct accompaniment of new mothers to the EID suite,
increasing privacy, and opening a medical record for infants prior to post-partum discharge. In
Phase 2, we added enhanced referral activity as an item on the maternity register to standardize the
process of referral.
Main outcome measure(s)—The proportion of HIV-infected mothers who accessed EID for
their infant <90 days of life.
Results—We tracked mother/infant pairs from June 2009 to March 2011 (Phase 0: N=144; Phase
1: N=479; Phase 2: N=168), compared study measures for mother/infant pairs across intervention
phases with chi-square, estimated time-to-EID by Kaplan-Meier, and determined the likelihood of
EID by Cox regression after adjusting for likely barriers to follow-up. At baseline (phase 0),
25.7% of infants accessed EID <90 days. EID improved to 32.2% after Phase 1; only 17.3%
received enhanced referral. After Phase 2, 61.9% received enhanced referral and 39.9% accessed
EID, a significant three-phase improvement (p=0.007). In adjusted analysis, the likelihood of EID
at any time was higher in the Phase 2 group vs. Phase 0 (aHR:1.68, 95%CI:1.19-2.37, p=0.003).
Conclusions—Retention improved by 55% with a simple referral enhancement. Quality
improvement efforts could help improve care in Mozambique and other low-resource countries.
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INTRODUCTION
In 2009, an estimated 370,000 children acquired HIV infection through vertical
transmission; while this number represents a 24% reduction in new infections since 2001,
the persistence of new infections from mother-to-child transmission highlights the continued
importance of HIV testing of at-risk infants.1 Successful prevention of mother-to-child
transmission (PMTCT) of HIV remains a challenge especially in many resource-limited
settings where HIV is highly prevalent, making testing of exposed infants particularly
important.1–5 Early infant diagnosis (EID) of HIV using dried-blood spot polymerase chain
reaction testing has been shown to be feasible and effective for use in these settings, and
allows for prompt identification and treatment of infected infants.6,7 Since early
combination antiretroviral treatment (cART) significantly reduces infant mortality from HIV
infection, successful EID programs are a crucial part of efforts to reduce the burden of HIV
disease.8
Despite the importance of EID, program performance in many resource-limited settings has
been disappointing, and factors such as patient attrition remain important barriers to higher
uptake of testing.9–12 Infants who fail to access EID, in addition to missing the opportunity
for prompt diagnosis of early HIV transmission, are deprived of the other HIV-related
services bundled with testing, such as cotrimoxazole prophylaxis, breastfeeding counseling
and testing for late transmission of infection. While socioeconomic factors are often cited as
drivers of poor access to EID,4,5,10,13 there is increasing attention to the role that
strengthening health systems may play in improving access and other program
outcomes.9,14–16
In our previous work at one district hospital in Zambézia Province, Mozambique, we found
that only 25% of all HIV-exposed infants born at the hospital returned for EID, though 49%
of their mothers returned for their own HIV care.17 We hypothesized that this discrepancy
was due in part to operational factors, and tested the idea that quality improvement methods
could be used to design an intervention to improve infant retention in the EID programs at
two district hospitals in Zambézia Province.
METHODS
Context
Zambézia Province is located in central Mozambique, is predominantly rural, and had an
estimated adult HIV prevalence of 12.6% in 2009.18 HIV screening is routinely offered to
women seeking prenatal care, and those who are HIV infected are offered antiretroviral
prophylaxis or cART when eligible by national guidelines.19 EID services are offered in
specialized clinics at all district hospitals in the province on an outpatient basis; these
services include HIV testing of at-risk infants by dried blood spot polymerase chain reaction
(DBS-PCR), provision of cotrimoxazole prophylaxis, and HIV-specific counseling and
support (Table 1). We conducted this study at two district hospitals in Zambézia Province, in
the districts of Alto Molócuè and Namacurra.
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Design, Population and Measures
We used the conceptual framework for quality improvement developed by Langley and
colleagues20 to assess the process of care delivered to HIV-infected mothers who gave birth
to a live infant at the two study hospitals, design and implement two phases of intervention,
and evaluate the interventions using a before/after study design. All HIV-infected mother/
HIV-exposed infant pairs born at the district hospitals of Alto Molócuè and Namacurra
between June 2009 and December 2010 were eligible for analysis; this 19 month interval
was defined as the enrollment period. The primary study outcome was the proportion of
hospital-born, HIV-exposed infants who successfully accessed EID within 90 days of birth.
Secondary outcomes were: (1) the proportion of infants who accessed EID regardless of
time; (2) the time to the initial EID visit; (3) the proportion of post-partum, HIV-infected
women who received the study intervention; and (4) the proportion of HIV-exposed infants
who were tested for HIV by DBS-PCR. Demographic information routinely collected as part
of clinical care was abstracted as part of the study evaluation. Clinical data from all mother/
infant pairs was tracked for at least 3 months from birth; final data collection took place in
April 2011.
Process of EID Referral at Baseline (Phase 0)
All women who presented for labor at both study hospitals had their HIV-status ascertained
on intake; women with unknown HIV status or who tested negative more than three months
before delivery were given a rapid HIV test on an opt-out basis. Clinical data for each HIV-
infected mother were recorded in a maternity register; this included information such as
basic demographics, cART regimen and administration, and date/time of delivery. Post-
delivery, HIV-infected women were given post-partum counseling prior to discharge
regarding the need to return with their infants for EID in one month. Counseling was
conducted by the maternal/child health nurses and took place in an open maternity ward,
often proximate to other patients. After counseling was completed, mothers and infants were
discharged from the hospital. For infants that returned with their mothers to access EID, the
infant was enrolled in the EID clinic and basic demographic information about the mother
and the infant were recorded in a clinic register. An infant medical record was also
generated by the EID nurse during enrollment. Mothers were counseled to return to the EID
clinic with their infant for subsequent visits. At both study sites, prenatal, maternity, and
EID services took place in three separate structures within a roughly 50-meter radius on the
hospital grounds.
Phase 1 Intervention
Staff were introduced to the Langley, et al. model for quality improvement (QI)20 and were
given the opportunity to participate in the process of designing an intervention aimed at
impacting infant retention in EID. This model of QI conceptualizes the process of
improvement around the Plan-Do-Study-Act (PDSA) Cycle. The model guides the process
of: (1) setting specific aims for improvement, mapping the process of care to identify key
barriers, and developing an intervention to address those barriers (Plan); (2) implementing a
pilot intervention (Do); (3) evaluating the effectiveness of the pilot intervention (Study); and
(4) scaling, modifying or discarding the intervention based on that evaluation (Act). The
model is iterative, and the goal is for each PDSA cycle to incorporate the experience of the
previous phase of improvement to achieve better outcomes over time.
We conducted unstructured interviews with maternal/child nursing staff at both hospitals,
and revealed several potential barriers facing HIV-infected women that could possibly
prevent EID access for their newborn. We focused discussion on barriers that could be
possibly overcome with a clinic-based intervention. Staff identified the standard process of
referral to the EID clinic during maternity discharge as a potential target for improvement
Ciampa et al. Page 3













for three reasons: (1) after standard referral counseling, many women lacked adequate
knowledge of the need for EID or the location of EID services; (2) the lack of privacy for
women during referral counseling possibly increased stigma and decreased the effectiveness
of counseling; and (3) the ability to track HIV-exposed infants who dropped out of care was
limited by the practice of deferring initiation of the medical record until the time of the
initial EID visit.
To address these barriers, several nurses working in Namacurra district hospital described
their attempt to enhance the process of referral to EID for their post-partum patients by
offering to accompany them to the site of EID at the time of maternity discharge. Within the
EID suite, these nurses offered counseling in a private setting and initiated a medical record
for infants prior to discharge (Figure 1). After this idea was introduced to all nursing staff at
both study hospitals, staff agreed to implement enhanced referral as standard practice at both
sites in September 2009 as a Phase 1 intervention. This intervention had three components:
(1) all HIV-infected, post-partum women who gave birth in the maternity ward would be
offered the opportunity to be accompanied by one of the maternity nurses to the site of EID
services prior to discharge; (2) in the privacy of the EID clinic suite, a mother would be
offered HIV counseling by the accompanying nurse that focused on care of her at-risk infant
and the need for EID; and (3) information about the newborn infant would be recorded in
the clinic register and a medical record would be generated.
Phase 2 Intervention
In August 2010, we reviewed data from the first phase of improvement and performed an
interim analysis to evaluate the effectiveness of enhanced referral on retention; early results
were promising and published previously.21 To further improve outcomes, a second phase of
improvement was introduced aimed at improving the proportion of eligible women who
received enhanced referral at both sites. Staff feedback indicated that factors such as staff
turnover and difficulty remembering to offer enhanced referral to patients in the context of
their other duties were major barriers to offering enhanced referral to more patients.
With these barriers in mind, we sought to standardize the process of referral by adding a
column in the maternity register for nurses to sign if they had offered their post-partum
patient enhanced referral and accompanied her to the EID suite. Staff felt that this
intervention would improve recall, allow for accountability, and allow them to document
this activity in the same way they did for their other clinical duties. This intervention was
formally implemented at both sites in August 2010.
Data Analysis
The study protocol was reviewed and approved by the National Committee of Bioethics for
Health in Mozambique and the Institutional Review Board of Vanderbilt University. Both
committees approved a waiver of informed consent for participants.
We reviewed mothers’ charts and abstracted relevant data of all HIV-infected mothers that
delivered a live infant from June 1, 2009 through September 11, 2009 (Phase 0), September
12, 2009 through August 20, 2010 (Phase 1) and August 21 through December 31, 2010
(Phase 2). Maternal/child follow-up for EID and infant HIV testing by DBS-PCR were
determined by review of the maternity and EID service register. Maternal names, home
village and infant date-of-birth were abstracted from the maternity register for all HIV-
infected/HIV-exposed infant pairs; maternal name, home village and infant date-of-birth
were abstracted from EID clinic registers. Mother/infant pairs with matched, identifiable
information on both registries were considered to have accessed EID. All mother/infant pairs
Ciampa et al. Page 4













were tracked from the time of birth until either an initial EID visit or the end of the study
period (March 2011).
Selected sociodemographic characteristics of the study population were reported as medians
or proportions; these were tabulated to describe woman/infant pairs in each interventional
phase and separately by receipt of standard vs. enhanced referral. Pearson’s chi squared test
was used to compare the characteristics of woman/infant pairs in each intervention phase,
and separately for pairs who received standard vs. enhanced referral. We compared the
aggregate rate of infant EID access before (Phase 0) and after implementation of enhanced
referral (Phase 1) and the register of maternity activities (Phase 2) using an intention-to-treat
analysis. The proportion of mothers who received enhanced referral, infants who accessed
EID within 90 days of life, infants who accessed EID regardless of time, and the infants who
were tested for HIV by DBS-PCR were compared across intervention phases, assessing
statistical significance by the chi-squared test for trend. Kaplan-Meier estimates were used
to compute time-to-EID access by intervention phase; estimates were compared by log-rank
test. A second set of Kaplan-Meier estimates were used to compute time-to-EID by receipt
of enhanced vs. standard referral to estimate the effectiveness of each intervention by per-
protocol analysis. Cox proportional hazard models compared time-to-EID by intervention
phase (intention-to-treat) and by referral type (per-protocol). These models were adjusted for
known demographic predictors to follow-up (selected a priori), including maternal age,
source of income, number of children, cART status, distance from home to the hospital (≥or
<10 km) and hospital site. Missing demographic information was accounted for using
multiple imputation methods.
RESULTS
A total of 791 records representing discrete mother/infant pairs from hospital births between
June 2009 and December 2010 were included in analyses (Phase 0: N=144, Phase 1: N=479,
Phase 2: N=168). During the 19-month study enrollment period, 507 women delivered at the
district hospital in Namacurra and 284 delivered in Alto Molócuè. Mothers were
predominately young (median age, 22 years), worked in agriculture (78.0%), and lived
within 10 km of the district hospital (82.4%). In the total sample, 19.2% of women were
receiving cART during pregnancy (Table 2). While there were no statistically significant
differences in demographic characteristics between women in the Phase 0 and Phase 1
populations, women in the Phase 2 population were more likely to have jobs in agriculture,
to live ≥10 km from the hospital and to be receiving cART for their HIV infection. A greater
proportion of women who received enhanced referral were receiving cART compared to
those who received standard referral (28.0% vs. 15.3%, p<0.001). Women who received
enhanced referral also had a higher median number of children (2 vs. 1, p<0.001). There
were no statistically significant differences for women in the enhanced vs. standard referral
group for median age, occupation type, or distance to the hospital (Table 3).
At baseline (Phase 0), 9.0% of post-partum women received enhanced referral and 25.7%
returned to access EID for their infant within 90 days. The women who received enhanced
referral during Phase 0 reflect the work of the nurses in Namacurra who developed the
intervention prior to the commencement of the present study. After implementation of the
Phase 1 intervention, 17.3% of women received enhanced referral, and 32.2% accessed EID
for their infant within 90 days. After implementation of the Phase 2 intervention, 61.9% of
women received enhanced referral, and 39.9% accessed EID within 90 days. Improvement
was statistically significant for both receipt of enhanced referral (p-trend<0.001) and EID (p-
trend=0.007) across the interventional phases. Likewise, the proportion of mother/infant
pairs who accessed EID at any time point improved significantly after the two intervention
phases (38.2% vs. 40.5% vs. 58.9%, p-trend<0.001), as did the proportion of infants who
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were tested for HIV with DBS-PCR during the initial EID visit (28.5% vs. 34.0% vs. 51.2%,
p <0.001) (Table 4). For women who received standard referral, there was no evidence of
change across intervention phases in the proportion who accessed EID for their infants
within 90 days (26.7% vs. 28.0% vs. 21.9%, p-trend=0.6) or at any follow-up time (39.7%
vs. 36.4% vs. 31.3%, p-trend=0.5).
Figure 2 depicts the time to EID access for mother/infant pairs by intervention phase and by
receipt of standard vs. enhanced referral. In multivariable analyses adjusting for maternal
age, number of children at home, distance from home to the health center, source of income,
maternal cART status and hospital site, there was a small, non-significant increase in the
likelihood of accessing EID for mother/infant pairs during the Phase 1 vs. Phase 0
intervention (aHR 1.17, 95%CI 0.86-1.58, p=0.3). In contrast, there was a statistically
significant increase in the likelihood of accessing EID for those mother/infant pairs in the
Phase 2 group relative to those at baseline (aHR 1.68, 95%CI 1.19-2.37, p=0.003). Mother/
infant pairs who received enhanced referral had a significantly increased rate of EID access
at any time compared to those who received standard referral (66.0% vs. 36.6%, p<0.001).
There was a significant increase in the likelihood of accessing EID for women who received
enhanced vs. standard referral in multivariable analysis (aHR 1.93, 95%CI 1.53-2.44,
p<0.001).
DISCUSSION
With two successive interventions that focused on improving health systems barriers, the
proportion of mother/infant pairs that succeeded in accessing EID within three months of
life improved by 55% at two rural hospitals in Mozambique. Even after accounting for other
known predictors of EID access, women who received enhanced referral were nearly twice
as likely to obtain EID for their infants compared to those who received standard care.
Enhanced referral improved on standard care by more tightly linking maternity and EID
services through direct accompaniment and by providing privacy for women during
counseling; these enhancements potentially led to more women seeking EID for their
infants. Incorporating enhanced referral into the routine documentation of maternity staff
improved implementation by providing a prompt for providers and a method for clinic
leaders to give feedback to individual providers. The study interventions were simple,
required no additional staff to execute, and were well accepted by the staff and patients. The
increased number of at-risk infants who accessed EID services did not result in less
consistent delivery of infant HIV PCR testing, suggesting that improving one care delivery
component did not overwhelm another. These practical, logistical factors are particularly
important for severely resource-constrained settings such as rural Mozambique.22
This study demonstrates the benefit that can be realized by using a quality improvement
approach that fosters a partnership with front-line staff to improve performance at the local
level. Enhanced referral was developed by a handful of nurses in response to their direct
experience of patient need, and thus was based on contextual information that is often
unavailable to those working at the programmatic level. Input from the program level
provided data that acted as an objective measure of performance — something that was
normally unavailable to staff — and served as an important motivating agent for change.
The quality improvement approach enabled an idea that succeeded on an individual level to
be spread to a larger context, on a scale that could impact an important programmatic
outcome. Since the study team interacted with staff on two brief occasions during Phase 1
and 2 planning, these interventions were sustained only by the daily action of local staff who
felt a sense of ownership of the ideas they helped create.
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The strengths of this study were the simplicity of the interventions, the magnitude of impact
on a program indicator with significant clinical relevance, and an evaluation that accounted
for known confounders. Findings from the study are limited by the uncontrolled study
design and the possibility that unmeasured confounding, especially selection bias, may have
had an impact on our results. While some differences between women who received
standard vs. enhanced referral, such as the higher proportion of women on cART in the
enhanced referral group, were accounted for in multivariable modeling, factors such as the
time of discharge, content of counseling and relation of enhanced referral delivery to
individual providers were not measured and may be confounding. While we cannot exclude
the possibility of a secular trend accounting for the improvement over time noted in our
results, the association of receipt of enhanced referral and follow-up and the lack of
improvement in follow-up over time for women receiving standard care argues strongly
against this as a significant factor. The study was not designed to measure mother/infant
pairs who did not receive EID due to infant mortality, or who may have accessed EID at
other health facilities due to migration; since EID services are centralized and the distance
between hospitals that provide these services is substantial, misclassification from migration
is likely minimal. The name-matching technique used to classify mother/infant pairs as
receiving enhanced referral and EID was another source of potential misclassification, but
this is a conservative bias that, if present, would underestimate the impact of our program.
The study was not designed to capture delivery of other EID clinic services, such as
cotrimoxazole prophylaxis or breast-feeding counseling, that are also important
interventions delivered to HIV-infected mother/HIV-exposed infant pairs.
While there was a significant improvement in both implementation of enhanced referral and
initial follow-up for EID, approximately 40% of eligible mothers after the second phase of
intervention did not receive the study intervention; a similar proportion failed to return for
EID. While this study was not designed to explore factors that limited delivery of enhanced
referral after the second interventional phase, barriers such as limited nurse staffing and high
staff turnover are likely to be important. Mothers may have opted out of enhanced referral
due to HIV-related stigma or fear of disclosure. The rate of increase in the proportion of
women/infant pairs receiving enhanced referral was higher than the rate of increase in EID
access within 90 days, while the rate of access to EID at any time point was more in-line
with the increase in enhanced referral. It may be that enhanced referral was more effective in
encouraging follow-up than it was in encouraging prompt follow-up; access to early EID
may be more sensitive to sociodemographic factors such as access to transportation.
The study was not designed to discern if there are specific factors that make enhanced
referral more or less effective on an individual basis; for instance, women who possess a
high level of knowledge about HIV may not benefit additionally from enhanced referral.
Since 44% of women who received enhanced referral did not access EID with their infants,
there are barriers to access that our interventions did not address. Our study interventions
would have been strengthened by incorporating patients’ perspectives on barriers to EID and
the acceptability of enhanced referral into our improvement strategy; both are strategies we
plan to incorporate in future work. Additionally, since infants whose mothers received
enhanced referral had medical records initiated prior to discharge, those rosters could be
used in future interventions to promote active community searching for HIV-exposed infants
who had not accessed EID.
Quality improvement methods have been cited as crucial tools to strengthen health systems
and make the best use of available resources in developing countries.15,16 Despite the clear
potential for improving processes such as PMTCT and EID where successful outcomes
depend on a cascade of events, this study is one of few that describe the application of
quality improvement methods toward that end.14,23,24 The interventions piloted during this
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study are straightforward to scale-up, and we are currently in the process of using a step-
wedge study design to evaluate enhanced referral at 10 district hospitals in Zambézia
Province. If our expanded intervention proves successful, we believe this model for
innovation and spread would have wide application to other problems and settings within
low and middle income countries.
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Flowcharts depicting the process of maternity and early infant diagnosis (EID) services
delivered to HIV-infected mothers/HIV-exposed infants during standard referral (Panel A)
and enhanced referral (Panel B).
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Kaplan-Meier estimates of time from birth to access of early infant diagnosis (EID) for HIV-
exposed infants before and after two intervention phases (Panel A), and by receipt of
enhanced vs. standard referral (Panel B).
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Table 1
Mozambique’s 2009–2010 National Guidelines for Prevention of Mother-to-Child HIV Transmission
(PMTCT) and Early Infant Diagnosis (EID)17,21
Maternal PMTCT Guidelines Infant PMTCT Guidelines Infant EID Guidelines†
• Combination antiretroviral therapy* if
CD4+ T-cell concentration ≤350 cells/µL
and/or mother has WHO stage III or IV
disease
• Zidovudine (300mg every 12 hours)
beginning at 28 weeks if CD4+ T-cell
concentration >350 cells/µL
• Zidovudine (300mg×1 dose), lamivudine
(150mg every 12 hrs×2 doses),
nevirapine (200mg×1 dose) during labor
• Zidovudine (300mg) and lamivudine
(150mg) every 12 hours for 1 week post-
partum
• Nevirapine (2mg/kg ×1
dose) at delivery
• Zidovudine (4mg/kg every
12 hours) from birth until
4 weeks post-partum
• Exclusive breast-feeding
through 6 months of age
• HIV PCR testing at 4 weeks,
and repeated if clinical
suspicion of HIV infection
develops < 9 months of age
• Cotrimoxazole (5mg/kg daily)
initiated at 4 weeks
• HIV antibody testing‡ at 9
months and at either 18 months




Combination antiretroviral therapy (cART) first-line regimen: zidovudine (300mg), lamivudine (150mg), and nevirapine (200mg) every 12 hours.
†
At-risk infants are followed monthly in the EID clinic, starting at 4 weeks of life. Infants diagnosed with HIV infection are referred for cART
initiation.
‡
Determine® and UniGold™ rapid immunoassay tests for HIV, used sequentially.
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Table 2
Characteristics of post-partum, HIV-infected mothers during each phase of improvement
Characteristic Total Phase 0 Phase 1 Phase 2
N=791 N=144 N=479 N=168
Median Maternal Age (Years, IQR) 22 (19–27) 23 (20–28) 22 (19–26) 23 (20–27)
Median Number of Children (IQR) 1 (1–3) 1 (1–3) 1 (1–2) 2 (1–3)
Maternal Occupation, %
   Agriculture 78.0 77.1 74.8 87.5
   Job outside home 11.0 9.2 12.2 9.4
   Student 11.0 13.8 13.0 3.1
Distance from Hospital, %
   < 10 km 82.4 87.2 85.3 70.5
   ≥ 10 km 17.6 12.8 14.7 29.5
Mother on cART, % 19.2 18.2 15.7 30.8
Phase 0 (baseline): June 1—September 11, 2009
Phase 1 improvement: September 12, 2009—August 20, 2010
Phase 2 improvement: August 21—December 31, 2010
cART = combination antiretroviral therapy
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Table 3
Characteristics of 791 women/infant pairs who received standard and enhanced referral to Early Infant
Diagnosis Services





Median Maternal Age (Years) 22 22 0.4
Median Number of Children 1 2 <0.001
Maternal Occupation, % 0.7
   Agriculture 78.3 77.2
   Job outside home 10.3 12.5
   Student 11.3 10.3
Distance from Hospital, %
   ≥ 10 km 16.3 20.4 0.2
Mother on cART, % 15.3 28.0 <0.001
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Table 4
Study outcomes for 791 HIV-infected mother/HIV-exposed infant pairs







Received enhanced referral, % 9.0 17.3 61.9 < 0.001
Initial EID visit (≤90 days), % 25.7 32.2 39.9 0.007
Initial EID visit (any time), % 38.2 40.5 58.9 <0.001
HIV PCR tested, % infants 28.5 34.0 51.2 <0.001
EID = Early Infant Diagnosis; PCR = Polymerase Chain Reaction
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